Literature DB >> 710676

Glucose tolerance in jejunoileal bypass for morbid obesity: a fifteen month follow-up.

O Bosello, F Armellini, M Pelloso, R Ostuzzi, A Ottolenghi, L A Scuro.   

Abstract

Twelve patients with body weight varying from 106 to 163 Kg, underwent jejunoileal bypass operations; their oral glucose tolerance tests (oGTT) were evaluated before the operation and one, five, and fifteen months afterwards. The lowering of the glycemic curve and the decrease of the insulinemia values during oGTT have been studied in relation to intestinal absorption deficit and weight loss. It is concluded that weight loss was the main factor determining the improvement of glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 710676

Source DB:  PubMed          Journal:  Diabete Metab        ISSN: 0338-1684


  5 in total

Review 1.  Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 kg/m2: an integrative review of early studies.

Authors:  M Fried; G Ribaric; J N Buchwald; S Svacina; K Dolezalova; N Scopinaro
Journal:  Obes Surg       Date:  2010-06       Impact factor: 4.129

2.  Residual Gastric Dilatation Interferes with Metabolic Improvements Following Sleeve Gastrectomy by Upregulating the Expression of Sodium-Glucose Cotransporter-1.

Authors:  Jun Xia; Qian He; Ming He; Guiwen Xu; Yizhou Tang; Yixing Ren
Journal:  Obes Surg       Date:  2019-10       Impact factor: 4.129

Review 3.  Targeting Islets: Metabolic Surgery Is More than a Bariatric Surgery.

Authors:  Xi Chen; Jingjing Zhang; Zhiguang Zhou
Journal:  Obes Surg       Date:  2019-09       Impact factor: 4.129

4.  Reduction of intestinal electrogenic glucose absorption after duodenojejunal bypass in a mouse model.

Authors:  Sheng Yan; Fei Sun; Zhiwei Li; Jie Xiang; Yuan Ding; Zhongjie Lu; Yang Tian; Hui Chen; Jinhua Zhang; Yan Wang; Penghong Song; Lin Zhou; Shusen Zheng
Journal:  Obes Surg       Date:  2013-09       Impact factor: 4.129

Review 5.  Effects of bariatric surgery on glucose homeostasis and type 2 diabetes.

Authors:  David Bradley; Faidon Magkos; Samuel Klein
Journal:  Gastroenterology       Date:  2012-08-08       Impact factor: 22.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.